Logo image of ABVE

ABOVE FOOD INGREDIENTS INC (ABVE) Stock Fundamental Analysis

USA - NASDAQ:ABVE - CA00373V1004 - Common Stock

2.93 USD
+0.36 (+14.01%)
Last: 10/3/2025, 8:20:36 PM
2.9398 USD
+0.01 (+0.33%)
After Hours: 10/3/2025, 8:20:36 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ABVE. ABVE was compared to 87 industry peers in the Food Products industry. ABVE may be in some trouble as it scores bad on both profitability and health. ABVE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ABVE has reported negative net income.
ABVE had a positive operating cash flow in the past year.
In the past 5 years ABVE always reported negative net income.
In the past 5 years ABVE reported 4 times negative operating cash flow.
ABVE Yearly Net Income VS EBIT VS OCF VS FCFABVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

The Return On Assets of ABVE (-107.17%) is worse than 91.01% of its industry peers.
Industry RankSector Rank
ROA -107.17%
ROE N/A
ROIC N/A
ROA(3y)-21.86%
ROA(5y)-13.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABVE Yearly ROA, ROE, ROICABVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ABVE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABVE Yearly Profit, Operating, Gross MarginsABVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5 -10

1

2. Health

2.1 Basic Checks

ABVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ABVE remains at a similar level compared to 1 year ago.
Compared to 1 year ago, ABVE has a worse debt to assets ratio.
ABVE Yearly Shares OutstandingABVE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ABVE Yearly Total Debt VS Total AssetsABVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ABVE has an Altman-Z score of 1.44. This is a bad value and indicates that ABVE is not financially healthy and even has some risk of bankruptcy.
ABVE has a worse Altman-Z score (1.44) than 61.80% of its industry peers.
The Debt to FCF ratio of ABVE is 21.93, which is on the high side as it means it would take ABVE, 21.93 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 21.93, ABVE is in line with its industry, outperforming 49.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 21.93
Altman-Z 1.44
ROIC/WACCN/A
WACC7.25%
ABVE Yearly LT Debt VS Equity VS FCFABVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

ABVE has a Current Ratio of 0.23. This is a bad value and indicates that ABVE is not financially healthy enough and could expect problems in meeting its short term obligations.
ABVE has a Current ratio of 0.23. This is amonst the worse of the industry: ABVE underperforms 95.51% of its industry peers.
A Quick Ratio of 0.18 indicates that ABVE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.18, ABVE is doing worse than 94.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.18
ABVE Yearly Current Assets VS Current LiabilitesABVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

ABVE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -145.55%.
ABVE shows a strong growth in Revenue. In the last year, the Revenue has grown by 84.68%.
EPS 1Y (TTM)-145.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2053%
Revenue 1Y (TTM)84.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ABVE Yearly Revenue VS EstimatesABVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 100M 200M 300M

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ABVE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABVE Price Earnings VS Forward Price EarningsABVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABVE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 49.08
EV/EBITDA N/A
ABVE Per share dataABVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ABVE!.
Industry RankSector Rank
Dividend Yield N/A

ABOVE FOOD INGREDIENTS INC

NASDAQ:ABVE (10/3/2025, 8:20:36 PM)

After market: 2.9398 +0.01 (+0.33%)

2.93

+0.36 (+14.01%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-18 2024-11-18
Earnings (Next)N/A N/A
Inst Owners11.59%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap149.99M
AnalystsN/A
Price TargetN/A
Short Float %3.8%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF 49.08
P/OCF 25.2
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY2.04%
OCF(TTM)0.12
OCFY3.97%
SpS10.24
BVpS-1.61
TBVpS-1.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -107.17%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 0.58%
ROA(3y)-21.86%
ROA(5y)-13.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover6.52
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 21.93
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.18
Altman-Z 1.44
F-Score4
WACC7.25%
ROIC/WACCN/A
Cap/Depr(3y)596.86%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.21%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-145.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2053%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)84.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-145.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y715.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1299.37%
OCF growth 3YN/A
OCF growth 5YN/A